PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
 
J Exp Med. 1972 August 1; 136(2): 261–276.
PMCID: PMC2139203

TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION

Abstract

Dormant solid tumors were produced in vivo by prevention of neovascularization. When small fragments of anaplastic Brown-Pearce carcinoma were implanted directly on the iris in susceptible rabbits, they always vascularized. A characteristic growth pattern, consisting of prevascular, vascular, and late phases, was observed, which terminated with destruction of the eye within 2 wk. The beginning of exponential volume increase was shown to coincide with vascularization of the implant, as demonstrated by perfusion with intravenous fluorescein and by histologic sections. In contrast, implants placed in the anterior chamber, at a distance from the iris, did not become vascularized. After initial growth into spheroids, they remained arrested at a small size comparable to prevascular iris implants, for periods as long as 6 wk. Although dormant in terms of expansion, these avascular tumors contained a population of viable and mitotically active tumor cells. When reimplanted on the iris, vascularization was followed by rapid, invasive growth. These observations suggest that neovascularization is a necessary condition for malignant growth of a solid tumor. When a small mass of tumor cells is prevented from eliciting new vessel ingrowth from surrounding host tissues, population dormancy results. These data suggest that the specific blockade of tumor-induced angiogenesis may be an effective means of controlling neoplastic growth.

Full Text

The Full Text of this article is available as a PDF (1.1M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971 Feb 1;133(2):275–288. [PMC free article] [PubMed]
  • Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971 Nov 18;285(21):1182–1186. [PubMed]
  • Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg. 1972 Mar;175(3):409–416. [PubMed]
  • Folkman J, Cole P, Zimmerman S. Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg. 1966 Sep;164(3):491–502. [PubMed]
  • Greene HS. HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS : I. THE TRANSFER OF RABBIT TUMORS TO ALIEN SPECIES. J Exp Med. 1941 Mar 31;73(4):461–474. [PMC free article] [PubMed]
  • HADFIELD G. The dormant cancer cell. Br Med J. 1954 Sep 11;2(4888):607–610. [PMC free article] [PubMed]
  • FISHER B, FISHER ER. Experimental evidence in support of the dormant tumor cell. Science. 1959 Oct 9;130(3380):918–919. [PubMed]
  • Sugarbaker EV, Ketcham AS, Cohen AM. Studies of dormant tumor cells. Cancer. 1971 Sep;28(3):545–552. [PubMed]
  • FISHER B, FISHER ER. Experimental studies of factors influencing hepatic metastases. III. Effect of surgical trauma with special reference to liver injury. Ann Surg. 1959 Oct;150:731–744. [PubMed]
  • PLENK HP, SORENSON FM, EICHWALD EJ. The time interval between tumor inoculation and metastatic spread to the lymph nodes. Cancer Res. 1954 Sep;14(8):580–581. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press